Endometrial Cancer Clinical Trials (as in March 2017)

ENGOT-EN1-I/NSGO/FANDANGO

Leading group: NSGO

Clinical Trial Study: Randomized phase II trial of first-line combination chemotherapy with BIBFI 120 or placebo for patients with advanced or reccurrent cancer. (M. R. Mirza)

Number of patients accrued: 148

Planned number of patients: 150

Participating groups:

BGOG, GINECO, NOGGO

 

 

ENGOT-EN2/NSGO/DGCG/EORTC-55102

Leading group: NSGO

Clinical Trial Study: Adjuvant chemotherapy in node negative endometrial carcinoma. (M. R. Mirza)

Number of patients accrued: TBA

Planned number of patients: 240

Participating groups:

BGOG, CEEGOG, EORTC, GEICO, ISGO, MaNGO, MITO, NOGGO, (C-COG)

 

 

ENGOT-EN3/NSGO/PALEO

Leading group: NSGO

Clinical Trial Study: A randomized phase II trial of Palbociclib in combination with letrozole versus letrozole for patients with oestrogen receptor positive recurrent endometrial cancer

Number of patients accrued: 78

Planned number of patients: 80

Participating groups:

GEICO, MITO, NOGGO

 

 

ENGOT-EN4/NCRI/STATEC

Leading group: NCRI

Clinical Trial Study:

STATEC: A randomised trial of non-Selective versus selective adjuvant Therapy in high risk Apparent sTage 1 Endometrial Cancer

Number of patients accrued: will start in 2017

Planned number of patients: 2000

Participating groups:

DGOG, (ANZGOG, KGOG)

 

 

ENGOT-EN5/BGOG- EN5/SIENDO

Leading group: BGOG

Clinical Trial Study: A randomized phase III trial of maintenance with Selinexor/placebo after combination chemotherapy for patients with advanced or reccurent endometrical cancer

Number of patients accrued: TBA

Planned number of patients: 126

Participating groups:

NSGO, other groups under discussion

 

Up Coming ENGOT Meeting

Frankfurt, Germany, October 12-13, 2017

Don't miss out on the latest updates

Save the Date!

You May Also Like

GCA WORKSHOPS

Watch the Webcasts 

 

Read More

CLINICAL TRIALS

Latest Published Research

 

Read More

FOR PATIENTS

Key Insights

 

Read More

ESGO 2017 Congress

Clinical Trials Session

 

Read More